1. World Health Organization. Obesity and overweight. WHO. 2018.
2. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M.. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 91 million participants.
Lancet 2011;377:557-67. PMID:
10.1016/s0140-6736(10)62037-5. PMID:
21295846.
3. Garawi F, Devries K, Thorogood N, Uauy R.. Global differences between women and men in the prevalence of obesity: is there an association with gender inequality?
Eur J Clin Nutr 2014;68:1101-6. PMID:
10.1038/ejcn.2014.86. PMID:
24918120.
4. Hales CM, Fryar CD, Carroll MD, Freedman DS, Oqden CL.. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016.
JAMA 2018;319:1723-5. PMID:
10.1001/jama.2018.3060. PMID:
29570750.
6. Oh C, Jho S, No JK, Kim HS.. Body composition changes were related to nutrient intakes in elderly men but elderly women had a higher prevalence of sarcopenic obesity in a population of Korean adults.
Nutr Res 2015;35:1-6. PMID:
10.1016/j.nutres.2014.07.018. PMID:
25524331.
7. Karvonen-Gutierrez C, Kim C.. Association of mid-life changes in body size, body composition and obesity status with the menopausal transition.
Healthcare (Basel) 2016;4:42PMID:
10.3390/healthcare4030042.
8. Amarapurkar D, Kamani P, Patel N, Gupte P, Kumar P, Agal S, Baijal R, Lala S, Chaudhary D, Deshpande A.. Prevalence of non-alcoholic fatty liver disease: population based study.
Ann Hepatol 2007;6:161-3. PMID:
17786142.
9. Milić S, Lulić D, Štimac D.. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
World J Gastroenterol 2014;20:9330-7. PMID:
25071327.
10. Patell R, Dosi R, Joshi H, Sheth S, Shah P, Jasdanwala S.. Non-alcoholic fatty liver disease (NAFLD) in obesity. J Clin Diagn Res 2014;8:62-6.
11. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA.. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
Gastroenterology 2011;140:124-31. PMID:
10.1053/j.gastro.2010.09.038. PMID:
20858492.
12. Feng RN, Du SS, Wang C, Li YC, Liu LY, Guo FC, Sun CH.. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
World J Gastroenterol 2014;20:17932-40. PMID:
10.3748/wjg.v20.i47.17932. PMID:
25548491.
13. Armstrong MJ, Houlihan DD, Bentham L, Shaw JC, Cramb R, Olliff S, Gill PS, Neuberger JM, Lilford RJ, Newsome PN.. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort.
J Hepatol 2012;56:234-40. PMID:
10.1016/j.jhep.2011.03.020. PMID:
21703178.
15. Michelotti GA, Machado MV, Diehl AM.. NAFLD, NASH and liver cancer.
Nat Rev Gastroenterol Hepatol 2013;10:656-65. PMID:
10.1038/nrgastro.2013.183. PMID:
24080776.
16. Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, Ahmed A.. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.
Gastroenterology 2015;148:547-55. PMID:
10.1053/j.gastro.2014.11.039. PMID:
25461851.
17. St George A, Bauman A, Johnston A, Farrell G, Chey T, George J.. Independent effects of physical activity in patients with nonalcoholic fatty liver disease.
Hepatology 2009;50:68-76. PMID:
19444870.
18. Contreras-Zentella ML, Hernández-Muñoz R.. Is liver enzyme release really associated with cell necrosis induced by oxidant stress?
Oxid Med Cell Longev 2016;2016:3529149PMID:
10.1155/2016/3529149. PMID:
26798419.
19. Botros M, Sikaris KA.. The de ritis ratio: the test of time.
Clin Biochem Rev 2013;34:117-30. PMID:
24353357.
20. Bray GA.. Medical consequences of obesity.
J Clin Endocrinol Metab 2004;89:2583-9. PMID:
15181027.
21. Parati G, Lombardi C, Narkiewicz K.. Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk.
Am J Physiol Regul Integr Comp Physiol 2007;293:R1671-83. PMID:
10.1152/ajpregu.00400.2007. PMID:
17652356.
22. Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A.. The interaction of hepatic lipid and glucose metabolism in liver diseases.
J Hepatol 2012;56:952-64. PMID:
10.1016/j.jhep.2011.08.025. PMID:
22173168.
23. Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB. NASH CRN Research Group. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.
Am J Gastroenterol 2011;106:460-8. PMID:
10.1038/ajg.2010.488. PMID:
21206486.
24. García-Monzón C, Lo Iacono O, Mayoral R, González-Rodríguez A, Miquilena-Colina ME, Lozano-Rodríguez T, García-Pozo L, Vargas-Castrillón J, Casado M, Boscá L, Valverde AM, Martín-Sanz P.. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
J Hepatol 2011;54:142-52. PMID:
20888662.
25. Kantartzis K, Machann J, Schick F, Fritsche A, Häring HU, Stefan N.. The impact of liver fat vs visceral fat in determining categories of prediabetes.
Diabetologia 2010;53:882-9. PMID:
10.1007/s00125-010-1663-6. PMID:
20099057.
26. Yin X, Zheng F, Pan Q, Zhang S, Yu D, Xu Z, Li H.. Glucose fluctuation increased hepatocyte apoptosis under lipotoxicity and the involvement of mitochondrial permeability transition opening.
J Mol Endocrinol 2015;55:169-81. PMID:
10.1530/jme-15-0101. PMID:
26464382.
27. American Gastroenterological Association. American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease.
Gastroenterology 2002;123:1702-4. PMID:
12404244.
28. Shamsoddini A, Sobhani V, Ghamar Chehreh ME, Alavian SM, Zaree A.. Effect of aerobic and resistance exercise training on liver enzymes and hepatic fat in iranian men with nonalcoholic fatty liver disease.
Hepat Mon 2015 15:e31434. PMID:
10.5812/hepatmon.31434.
29. Skrypnik D, Ratajczak M, Karolkiewicz J, Mądry E, Pupek-Musialik D, Hansdorfer-Korzon R, Walkowiak J, Jakubowski H, Bogdański P.. Effects of endurance and endurance-strength exercise on biochemical parameters of liver function in women with abdominal obesity.
Biomed Pharmacother 2016;80:1-7. PMID:
10.1016/j.biopha.2016.02.017. PMID:
27133033.
30. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018.
Diabetes Care 2018;41:S13-27. PMID:
10.2337/dc18-s002. PMID:
29222373.
31. World Health Organization. Regional Office for the Western Pacific. The Asian-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia. 2000. p. 18.
32. Dungan KM.. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
Expert Rev Mol Diagn 2008;8:9-19. PMID:
10.1586/14737159.8.1.9. PMID:
18088226.
33. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC.. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
Diabetologia 1985;28:412-9. PMID:
3899825.
34. Woreta TA, Alqahtani SA.. Evaluation of abnormal liver tests.
Med Clin North Am 2014;98:1-16. PMID:
24266911.
35. Bacchi E, Negri C, Targher G, Faccioli N, Lanza M, Zoppini G, Zanolin E, Schena F, Bonora E, Moghetti P.. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial).
Hepatology 2013;58:1287-95. PMID:
10.1002/hep.26393. PMID:
23504926.
36. Balducci S, Cardelli P, Pugliese L, D'Errico V, Haxhi J, Alessi E, Iacobini C, Menini S, Bollanti L, Conti FG, Nicolucci A, Pugliese G. Italian Diabetes Exercise Study (IDES) Investigators. Volume-dependent effect of supervised exercise training on fatty liver and visceral adiposity index in subjects with type 2 diabetes The Italian Diabetes Exercise Study (IDES).
Diabetes Res Clin Pract 2015;109:355-63. PMID:
10.1016/j.diabres.2015.05.033. PMID:
26047682.
37. Lee S, Bacha F, Hannon T, Kuk JL, Boesch C, Arslanian S.. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial.
Diabetes 2012;61:2787-95. PMID:
10.2337/db12-0214. PMID:
22751691.
38. Straznicky NE, Lambert EA, Grima MT, Eikelis N, Nestel PJ, Dawood T, Schlaich MP, Masuo K, Chopra R, Sari CI, Dixon JB, Tilbrook AJ, Lambert GW.. The effects of dietary weight loss with or without exercise training on liver enzymes in obese metabolic syndrome subjects.
Diabetes Obes Metab 2012;14:139-48. PMID:
10.1111/j.1463-1326.2011.01497.x. PMID:
21923735.
39. Larson-Meyer DE, Newcomer BR, Heilbronn LK, Volaufova J, Smith SR, Alfonso AJ, Lefevre M, Rood JC, Williamson DA, Ravussin E. Pennington CALERIE Team. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.
Obesity (Silver Spring) 2008;16:1355-62. PMID:
10.1038/oby.2008.201. PMID:
18421281.
40. Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava JL, Wing RR.. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.
Hepatology 2010;51:121-9. PMID:
10.1002/hep.23276. PMID:
19827166.
41. Tamura Y, Tanaka Y, Sato F, Choi JB, Watada H, Niwa M, Kinoshita J, Ooka A, Kumashiro N, Igarashi Y, Kyogoku S, Maehara T, Kawasumi M, Hirose T, Kawamori R.. Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients.
J Clin Endocrinol Metab 2005;90:3191-6. PMID:
10.1210/jc.2004-1959. PMID:
15769987.
42. Shah K, Stufflebam A, Hilton TN, Sinacore DR, Klein S, Villareal DT.. Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults.
Obesity (Silver Spring) 2009;17:2162-8. PMID:
10.1038/oby.2009.126. PMID:
19390517.
43. Cuthbertson DJ, Shojaee-Moradie F, Sprung VS, Jones H, Pugh CJ, Richardson P, Kemp GJ, Barrett M, Jackson NC, Thomas EL, Bell JD, Umpleby AM.. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease.
Clin Sci (Lond) 2016;130:93-104. PMID:
26424731.
44. Damor K, Mittal K, Bhalla AS, Sood R, Pandey RM, Guleria R, Luthra K, Vikram NK.. Effect of progressive resistance exercise training on hepatic fat in Asian Indians with non-alcoholic fatty liver disease.
Br J Med Med Res 2014;4:114-24. PMID:
10.9734/bjmmr/2014/4845.
45. Stefan N, Kantartzis K, Häring HU.. Causes and metabolic consequences of fatty liver.
Endocr Rev 2008;29:939-60. PMID:
10.1210/er.2008-0009. PMID:
18723451.
46. Wellen KE, Hotamisligil GS.. Inflammation, stress, and diabetes.
J Clin Invest 2005;115:1111-9. PMID:
10.1172/jci25102. PMID:
15864338.
47. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS.. TLR4 links innate immunity and fatty acid-induced insulin resistance.
J Clin Invest 2006;116:3015-25. PMID:
10.1172/jci28898. PMID:
17053832.
48. Keating SE, Hackett DA, George J, Johnson NA.. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
J Hepatol 2012;57:157-66. PMID:
10.1016/j.jhep.2012.02.023. PMID:
22414768.
49. Sreenivasa Baba C, Alexander G, Kalyani B, Pandey R, Rastogi S, Pandey A, Choudhuri G.. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis.
J Gastroenterol Hepatol 2006;21:191-8. PMID:
16706832.
50. Kim MK, Baek KH, Kang MI, Park SE, Rhee EJ, Park CY, Lee WY, Oh KW.. Serum alkaline phosphatase, body composition, and risk of metabolic syndrome in middle-aged Korean.
Endocr J 2013;60:321-8. PMID:
10.1507/endocrj.ej12-0331. PMID:
23149655.